Kojic Acid Cream Base

1. INCI & CAS

INCI: Kojic Acid · CAS: 501-30-4

2. Role in the formula

Kojic acid is restricted or under review in several markets, including EU SCCS opinions on leave-on use. This guide does not claim a whitening drug. Confirm the destination limit before any scale-up. If the market disallows it, leave it out.

3. Typical use levels (formulation guide)

• Only where the destination rule allows, often at or below 1%

Dissolve carefully. Protect from light and air. Do not assume EU leave-on acceptance.

4. Regulatory sources & global compliance

• If Kojic Acid appears in CosIng, its entry is informational and does not approve a specific grade or finished cosmetic.
• Regulation (EC) No 1223/2009 requires a safety assessment covering the complete formulation with Kojic Acid before release of the finished cosmetic.
• Use current supplier documentation for the purchased Kojic Acid grade and verify applicable destination-market filings.

5. Safety & risk assessment

The stated concentration is a cosmetic-development reference; no drug approval or OTC status is conferred by this entry while finished-product patch and stability testing remain necessary.

6. Stability & packaging

Keep bulk material sealed, cool, and out of direct sunlight; where oxidation is a concern, evaluate airless or pump packaging; then verify formula stability and pack compatibility on the confirmed batch.

7. Claims language (Do / Don’t)

• Names kojic acid only as a restricted cosmetic guide

• The ingredient guidance cannot substantiate therapeutic outcomes, clinical cures, or a certification the finished SKU does not hold.
• This cosmetic entry naming Kojic Acid cannot verify whitening, acne treatment, antiperspirant action, sunscreen use, or hair-growth outcomes.

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

Glycerin fills a polyol-humectant role in the listed cosmetic formats. Read its percentage as formulation guidance, not an assay.

3. Typical use levels (formulation guide)

• The gels and serums use-level reference is 3–8% for the formula.
• The stated reference for creams is 2–5% as a formulation guide.
• For rinse-off, use 2–4% for the formula.

The water phase is the addition point for Glycerin; a separate melt is unnecessary.

4. Regulatory sources & global compliance

• If CosIng lists Glycerin, that listing remains ingredient information; check rules for the intended market and use.
• For cosmetics placed on the EU market, Regulation (EC) No 1223/2009 requires a safety assessment covering the complete formulation with Glycerin rather than for an ingredient name alone.
• Verify the purchased Glycerin grade using supplier data, alongside the applicable filing rules for the destination market.

5. Safety & risk assessment

This level is a cosmetic-formulation guide; it does not establish drug approval or OTC-monograph status with patch assessment and finished-formula stability testing still required.

6. Stability & packaging

Keep bulk supplies closed, cool, and protected from sunlight; consider an airless or pump format when oxidation sensitivity warrants it; use batch testing to verify stability and package compatibility.

7. Claims language (Do / Don’t)

• The formulation note describes Glycerin as part of a cosmetic direction focused on humectant function.

• This product entry does not demonstrate drug claims, cure claims, or a certification that is absent from the product records.
• This guide to Glycerin does not support skin whitening, acne care, sweat reduction, sun protection, or hair-growth outcomes.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

The guide uses plant-derived squalane, a stable hydrocarbon emollient, and does not specify mineral oil.

3. Typical use levels (formulation guide)

• The stated reference for gel-creams is 2–6% as a formulation guide.
• The level shown for dry oils is 10–30% as a formulation guide.
• The balms use-level reference is 5–15% as a formulation guide.

The guide places Squalane in the oil phase and calls for no high-shear wax processing.

4. Regulatory sources & global compliance

• An entry for Squalane in CosIng is not authorization for a material grade or completed cosmetic; review local requirements.
• Regulation (EC) No 1223/2009 sets the requirement for the complete cosmetic containing Squalane to receive its own safety assessment in the final product context.
• Confirm the received Squalane grade against supplier documentation, then verify the intended market's filing requirements.

5. Safety & risk assessment

The guide records a level for cosmetic formulation purposes; no drug approval or OTC status is conferred by this entry and the finished formula still needs patch and stability testing.

6. Stability & packaging

Keep bulk material sealed, cool, and out of direct sunlight; if oxidation risk calls for it, review a pump or airless format; check the finished batch's stability and package compatibility.

7. Claims language (Do / Don’t)

• The cosmetic concept for Squalane in this entry centers on a light-emollient role.

• The ingredient guidance is not evidence of drug effects, clinical cures, or unsupported product certifications.
• This guide to Squalane should not be cited in support of skin whitening, treatment of acne, sweat control, UV protection, or hair-growth results.